Guideline discordant diagnostic care: when do referrals not reflect guidelines for suspected cancer?
This study will look at how often GPs follow the guidelines and whether certain types of patients or patients with certain symptoms are more or less likely to be urgently referred when the guidelines suggest they should be. Read more
Are patients with high-normal platelet counts at increased risk of cancer?
Our previous work found that cancer risk was greatly increased for people with clinically high platelets (cells in the blood that enable clotting). The NORMA study will investigate whether people with platelet counts at the high end of the normal range are also at increased risk of cancer. Read more
Aids to cancer diagnosis in primary care
This study is part of a wider Health and Technology Assessment study whose overall aim is to understand the effectiveness, cost-effectiveness and current use of cancer diagnostic tools to aid decision-making in primary care. Read more
Abdominal pain in primary care: establishing a clinical profile and diagnostic pathway for identifying cancer
Abdominal pain is a symptom commonly reported to United Kingdom general practitioners. This research will help to guide GPs into providing appropriate action for patients with unexplained abdominal pain. Read more
The diagnostic utility of inflammatory markers in primary care: a prospective cohort study (PhD)
This project aims to find out whether blood tests called ‘inflammatory markers’ could help GPs to diagnose cancer. We will also look at whether they are useful for other important illnesses, such as infections and autoimmune conditions. Read more
Understanding missed diagnostic opportunities in bladder and kidney cancer (PhD)
This PhD project will use bladder and kidney cancer as exemplars to identify missed diagnostic opportunities in early cancer diagnosis. Read more
What is the clinical-effectiveness and cost-effectiveness of embedded risk-of-cancer assessment of patients in primary care: the ERICA trial
This is a cluster-randomised controlled clinical trial of electronic clinical decision support tools for six different cancer types in 710 English general practices. Read more